Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1073 | 942 | 1121 | 1148 | 1429 | 2389 |
Fund Return | 7.3% | -5.77% | 12.11% | 4.72% | 7.4% | 9.1% |
Place in category | 365 | 677 | 431 | 146 | 140 | 105 |
% in Category | 39 | 71 | 45 | 25 | 28 | 31 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Legal General US Index Trust C Acc | 3.76B | 27.84 | 12.09 | 15.28 | ||
Legal General US Index Trust C Dist | 901.34M | 27.74 | 12.07 | 15.27 | ||
Legal General US Index Trust I Acc | 1.78B | 27.75 | 12.04 | 15.23 | ||
Legal General US Index Trust I Dist | 1.8B | 27.69 | 12.02 | 15.22 | ||
Legal General US Index Trust F Acc | 587.92K | 26.93 | 10.90 | 14.79 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Global Life Sciences Fund U G | 3.86B | 5.16 | 5.09 | 10.55 | ||
Wellington Global Health Care EquiG | 2.02B | 6.70 | 4.03 | 11.14 | ||
Global Health Care Fund W Acc GBP | 112.16M | 6.90 | 3.02 | 9.41 | ||
Adamant Medtech I GBP | 1.64B | 10.76 | 0.98 | 12.16 | ||
Pharmaceuticals Index Trust I Acc | 530.37M | 7.70 | 5.13 | 9.70 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.67 | 762.55 | +1.14% | |
UnitedHealth | US91324P1021 | 6.67 | 529.84 | +1.95% | |
J&J | US4781601046 | 4.97 | 147.03 | +1.21% | |
AbbVie | US00287Y1091 | 4.65 | 170.18 | +0.58% | |
Novo Nordisk B | DK0062498333 | 4.42 | 581.0 | -0.10% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | BUY | Strong Buy |
Summary | Strong Buy | Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review